Since HA is the ligand of CD44, a highly expressed cancer stem cell marker on the osteosarcoma cell surface, the organic shell, HA-PEG polymer, could play a role in osteosarcoma targeting and sustained drug release (Morath et al., 2016; Liu et al., 2018). The gene discussed is CD44; the disease is osteosarcoma.